BUZZ-Alector stock surges after agreement with Genentech on an experimental Parkinson's disease drug
路透社2026/10/05 11:54October 5 - The stock price of pharmaceutical company Alector (ALEC.O) surged by 44.20% in pre-market trading, reaching $2.61. The company has entered into a global licensing agreement with Genentech for AL050, an experimental drug developed by ALEC for the treatment of Parkinson's disease. ALEC has granted Genentech the exclusive worldwide rights to develop and commercialize AL050. According to ALEC, the agreement will bring an upfront payment of $100 million and may result in milestone payments of up to $1.17 billion by 2029. The company retains ownership of its ABC technology platform for developing therapies for neurodegenerative diseases, as well as all rights to use the platform in its research and development pipeline. As of the close of the previous trading day, ALEC's stock price had risen by 16.03%. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Due to possible errors in automation or lack of context, Reuters does not guarantee the accuracy of the automated translation, which is provided solely for the convenience of readers. Reuters assumes no responsibility for any damage or loss caused by the use of the automated translation.)
October 5 - ** Shares of pharmaceutical company Alector (ALEC.O) surged 44.20% in pre-market trading, reaching $2.61
** The company reached a global licensing agreement with Genentech for AL050, ALEC's experimental drug for treating Parkinson's disease
** ALEC granted Genentech exclusive global rights to develop and commercialize AL050
** According to ALEC, the agreement includes a $100 million upfront payment and the possibility of milestone payments up to $1.17 billion by 2029
** The company retains ownership of its ABC technology platform for developing therapies for neurodegenerative diseases, as well as all rights for its use in its research and development pipeline
** As of the close of trading on the previous day, ALEC shares were up 16.03%
(To facilitate non-English speakers, Reuters provides its reporting automatically translated into several other languages. Automated translations may contain errors or lack necessary context, and Reuters does not guarantee the accuracy of the automated translation. The automated translation is provided solely for the convenience of readers. Reuters accepts no responsibility for any damages or losses that may arise from the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Reality of AI Agentic Payments in 2026
Exchange-Traded Funds Mixed, US Equities Rise After Midday
01:09 PM EDT, 10/06/2026 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded fund IWM fell and IVV edged higher. Actively traded Invesco QQQ Trust (QQQ) added 0.7%. US equity indexes rose as big-tech names helped the S&P 500 and the Nasdaq Composite hit fresh all-time highs intraday amid declining government bond yields and crude oil. Energy IShares US Energy ETF (IYE) and the State Street Energy Select Sector SPDR (XLE) were each up about 0.8%. Technology The State Street Technology Select Sector SPDR ETF (XLK) gained 0.8%; iShares US Technology ETF (IYW) added 0.7%, and iShares Expanded Tech Sector ETF (IGM) was 0.8% higher. The State Street SPDR S&P Semiconductor (XSD) climbed 1.4%, and iShares Semiconductor (SOXX) rose 0.6%. Financial The State Street Financial Select Sector SPDR (XLF) added 0.2%. Direxion Daily Financial Bull 3X Shares (FAS) advanced 0.5%, and its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), declined 0.4%. Commodities Crude oil rose 0.2%, and the United States Oil Fund (USO) added 0.3%. Natural gas gained 1.3%, and the United States Natural Gas Fund (UNG) was up 1.2%. Gold on Comex gained 0.7%, and the State Street SPDR Gold Shares (GLD) was up 0.4%. Silver rose 0.5%, and iShares Silver Trust (SLV) gained 0.3%. Consumer The State Street Consumer Staples Select Sector SPDR (XLP) was 1% higher, and the Vanguard Consumer Staples ETF (VDC) rose 1.1%. The State Street Consumer Discretionary Select Sector SPDR (XLY) added 1.1%. VanEck Retail ETF (RTH) was up 1%, and the State Street SPDR S&P Retail (XRT) edged up 0.3%. Healthcare The State Street Health Care Select Sector SPDR (XLV) slipped 0.1%, while iShares US Healthcare (IYH) shed 0.2%, and Vanguard Health Care ETF (VHT) fell 0.4%. IShares Biotechnology ETF (IBB) declined 2.1%. Industrial The State Street Industrial Select Sector SPDR (XLI) added 1.2%. Vanguard Industrials Index Fund (VIS) rose 1.1%, and iShares US Industrials (IYJ) gained 1.1%. Cryptocurrency In midday activity, bitcoin (BTC-USD) shed
US Dollar Index slips from its 18-month high
BUZZ-Venture Global shares rise as reports say the company is in talks with China on LNG sales
October 6th - LNG producer Venture Global (VG.N) shares rose 2.3% to $13.77. According to Bloomberg, due to the Iran war disrupting global LNG transport and prompting China to seek diversified supply sources, the company is negotiating LNG sales with more Chinese buyers. Venture Global has not immediately responded to a request for comment from Reuters. Bloomberg reports that Venture Global has held preliminary discussions for long-term contracts with at least three Chinese LNG importers. Of 18 brokerage firms, 11 have given the stock a "buy" or higher rating, and 7 have given a "hold" rating; the median target price is $16. Including intraday fluctuations, VG’s share price has more than doubled so far this year. (For the convenience of non-native English speakers, Reuters automatically translates its reports into several other languages. Because automated translation may contain errors or lack necessary context, Reuters makes no guarantee as to the accuracy of automated translations, which are provided solely for the convenience of readers. Reuters assumes no liability for any damages or losses caused by the use of the automated translation feature.)
Crypto prices
More
